期刊文献+

骨髓间质干细胞移植治疗DMD模型鼠的肌组织dystrophin/utrophin表达 被引量:7

Dystrophin and Utrophin Expression in Muscle Tissues of DMD Mouse Model afterTransplantation Treatment by Bone Marrow Mesenchymal Stem Cells
在线阅读 下载PDF
导出
摘要 目的观察骨髓间质干细胞(MSC)移植治疗Duchenne肌营养不良症(DMD)动物模型dko小鼠后肌组织dystrophin/utrophin的表达情况。方法用体外培养纯化的第5代MSC经尾静脉移植治疗dko小鼠,移植后5、10、15、20周分别取实验鼠腓肠肌组织做荧光免疫组化检测dystrophin/utrophin的表达,计算阳性纤维的平均光密度。结果传3代以上呈集落生长的MSC均一性好,静脉移植免疫反应低。移植后5~20周dko小鼠肌膜组织dystrophin/utrophin免疫荧光表达强度有随着时间逐渐递增的趋势,移植15周前后肌膜荧光带光密度有显著性差异(P=0.035)。结论MSC在体内外均具有强大的可塑性,通过血液循环MSC可趋向病变肌组织,并分化为表达dystrophin/utrophin的肌纤维,干细胞移植对dko小鼠肌萎缩组织有一定修复作用。 Objective To observe dystrophin and utrophin expression in muscle tissues of Duchenne muscular dystrophy(DMD)mouse model(dko mouse)after having been treated with bone marrow mesenchymal stem cells(MSC)transplantation. Methods The fifth generation of MSCs, cultured in vitro, was tran-splanted into dko mice by tail vein. The fluorescent expression of dystrophin and utrophin in gastrocn-emius muscle tissue of dko mouse was detected and the average optical density of positive fibers was calculated. Results MSCs that had been cultured for three generations had good homogeneousness and the immunological reaction after vein transplantation was low. There was an increasing tendency of dystrophin and utrophin fluorescent expression in sarcolemma of dko mouse within 5-20 weeks. Signi-ficant difference existed in fluorescent average optical density of positive fibers fifteen weeks before and after cell transplantation. Conclusions MSC has strong plasticity both in vitro and in vivo. MSC has a trend to reach the injured muscle tissues and turn into muscle fibers, which express dystrophin and utrophin. There is some plerosis function for myatrophy of dko mouse by MSC transplantation.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2004年第3期294-297,i004,共5页 Acta Academiae Medicinae Sinicae
基金 国家自然科学基金(30270732 30000057 30170337) 广东省科技攻关项目(2KM05501S) 广州市科委基金(2002J1-C0182)~~
关键词 DUCHENNE肌营养不良症 骨髓 间质于细胞 移植 Duchenne muscular dystrophy bone marrow mesenchymal stem cells transplantation
  • 相关文献

参考文献11

  • 1Koc ON, Lazarus HM. Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant, 2001, 27(3):235-239
  • 2Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells, 2001, 19(3):180-192
  • 3Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol, 2000, 28(8):875-884
  • 4Grounds MD, Garrett KL, Lai MC, et al. Identification of skeletal muscle precursor cells in vivo by use of MyoD1 and myogenic probes. Cell Tissue Res, 1992, 267(1):99-104
  • 5Ferrari G, Angelis GC, Coletta M, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science, 1998,279(5356): 1528-1530
  • 6Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature, 1999, 401(6751):390-394
  • 7Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest, 1999, 103(5):697-705
  • 8Fukuda K. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering.Artif Organs, 2001, 25(3):187-193
  • 9Wang JS, Shum-Tim D, Galipeau J, et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg, 2000, 120(5):999-1005
  • 10Deconinck AE, Rafael JA, Skinner JA, et al. Utrophindystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell, 1997, 90(4):717-727

二级参考文献1

  • 1刘焯霖,梁秀龄,潘锡榜.广东省部分地区152,318人口神经系统遗传病流行病学调查报告[J]中国神经精神疾病杂志,1985(06).

共引文献32

同被引文献87

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部